[DOI] [PMC free article] [PubMed] [Google Scholar] Beiroa D, Imbernon M, Gallego R, Senra A, Herranz D, Villarroya F, Serrano M, Fern J, Salvador J, Escalada J, 2014
Patients interested in weight management or considering semaglutide should discuss these results with their healthcare professionals, particularly regarding the potential for weight regain after stopping treatment and the implications for long-term weight management strategies
doi: 10.1089/met.2010.0025 [DOI] [PubMed] [Google Scholar] 57
Aquac Res 36(14)
Titration is central to any GLP-1 schedule
What makes semaglutide unique among GLP-1 agonists is its modified amino acid sequence and fatty acid side chain, which extends its half-life to approximately seven days